GILDER GAGNON HOWE & CO LLC - KYMERA THERAPEUTICS INC ownership

KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 127 filers reported holding KYMERA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of KYMERA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,137,924
-44.2%
81,865
-7.7%
0.02%
-39.3%
Q2 2023$2,039,949
-23.1%
88,732
-0.9%
0.03%
-36.4%
Q1 2023$2,651,766
+17.8%
89,496
-0.8%
0.04%
+4.8%
Q4 2022$2,251,043
+27.3%
90,186
+11.1%
0.04%
+35.5%
Q3 2022$1,768,000
-5.6%
81,194
-14.6%
0.03%
-6.1%
Q2 2022$1,872,000
-61.4%
95,073
-17.0%
0.03%
-26.7%
Q1 2022$4,846,000
-36.4%
114,506
-4.5%
0.04%
+4.7%
Q4 2021$7,616,000
-1.6%
119,953
-8.9%
0.04%
+7.5%
Q3 2021$7,736,000
+46.9%
131,694
+21.3%
0.04%
+53.8%
Q2 2021$5,266,000108,5780.03%
Other shareholders
KYMERA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Deer IX & Co. Ltd. 1,755,356$97,949,00048.97%
Trustees of Columbia University in the City of New York 463,298$28,724,00038.38%
AJU IB Investment Co., Ltd. 704,059$43,652,00016.52%
BVF INC/IL 2,630,658$163,101,0006.42%
Redmile Group, LLC 2,720,489$168,670,0002.04%
Bain Capital Life Sciences Investors, LLC 479,605$29,735,0001.87%
Rock Springs Capital Management LP 713,865$44,260,0000.94%
SPHERA FUNDS MANAGEMENT LTD. 147,700$9,157,0000.81%
HighVista Strategies LLC 17,117$1,061,0000.68%
Logos Global Management LP 110,920$6,877,0000.59%
View complete list of KYMERA THERAPEUTICS INC shareholders